Guides on ethylene oxide and chlorine dioxide contract sterilization — method selection, validation timelines, release pathways, and residuals — from a team that runs both methods.
May 2026· By Jim Kasic
A practical comparison of ethylene oxide and chlorine dioxide contract sterilization — material compatibility, residuals, device size, turnaround, and cost — so you pick the method your device actually needs.
Read article →May 2026· By Jim Kasic
Why device makers are evaluating chlorine dioxide as a low-emission, non-carcinogenic alternative to ethylene oxide — and where EO still wins.
Read article →May 2026· By Jim Kasic
The difference between overkill-method and lethal-rate (bioburden-based) sterilization release — and how to choose based on materials, cost, and testing burden.
Read article →May 2026· By Jim Kasic
A realistic timeline for ethylene oxide sterilization validation — from cycle development through IQ/OQ/PQ — plus the single-lot release path when you need product out the door.
Read article →May 2026· By Jim Kasic
Why small-batch ethylene oxide sterilization fits startups, clinical builds, and low-volume commercial devices — and how a six-chamber strategy avoids the warehouse-scale chamber problem.
Read article →May 2026· By Jim Kasic
How ethylene oxide and ethylene chlorohydrin residuals are limited under ISO 10993-7, how aeration controls them, and how in-house residual testing speeds release.
Read article →Our guides cover the framework. For a method recommendation and validation plan scoped to your device — EO or chlorine dioxide — talk to our team directly.
Request a Quote